June 8, 2022

Dr. Abhishek Tripathi discusses the 8-year survival outcomes from the CHAARTED trial for patients with advanced prostate cancer

June 7, 2022

Pancreatic neuroendocrine tumors: Capecitabine plus temozolomide gives longer PFS than temozolomide alone

June 7, 2022

E2108 evidence informs a discussion on systemic therapy vs surgery for de novo stage IV breast cancer

June 6, 2022

Novel drug combination demonstrates promising results in treating pancreatic neuroendocrine tumors

June 6, 2022

E2211: Dr. Pamela Kunz discusses the trial results and talks about the challenges of managing endocrine tumors

June 6, 2022

Dr. Michael Atkins discusses the DREAMseq trial in patients with advanced melanoma

June 5, 2022

Dr. Pamela Kunz on pancreatic neuroendocrine tumors: A final analysis of temozolomide or temozolomide plus capecitabine

June 5, 2022

Drug combination shows promise for treating pancreatic neuroendocrine tumors

June 4, 2022

E3311: No differences in survival outcomes based on tobacco history in HPV-associated head and neck cancer

ECOG-ACRIN Cancer Research Group